Identification of Potential Targets Linked to the Cardiovascular/Alzheimer's Axis through Bioinformatics Approaches

Francisco Andújar-Vera1,2,3, Cristina García-Fontana1,4,5, Raquel Sanabria-de la Torre1,6

  • 1Instituto de Investigación Biosanitaria de Granada, 18012 Granada, Spain.

Biomedicines
|February 25, 2022
PubMed

Insights

Researchers identified key proteins linking cardiovascular disease (CVD) and Alzheimer's disease (AD). Apolipoprotein E and haptoglobin were significant differentially expressed genes, offering potential therapeutic targets for both conditions.

Area of Science:

  • Biomedical research
  • Genomics
  • Proteomics

Background:

  • Alzheimer's disease (AD) and cardiovascular disease (CVD) share common molecular mechanisms beyond aging.
  • Investigating the CVD/AD axis is crucial for understanding shared pathologies.

Purpose of the Study:

  • To identify common molecular targets in the CVD/AD axis.
  • To pinpoint key proteins involved in both cardiovascular and neurodegenerative diseases.

Main Methods:

  • Analysis of genomic data from calcified and healthy femoral artery samples.
  • Construction of a protein-protein interaction network to identify differentially expressed genes (DEGs).
  • Application of centrality algorithms and proteomic analysis for target validation.

Main Results:

  • Apolipoprotein E and haptoglobin identified as DEGs in calcified arteries, suggesting roles in CVD/AD.
  • Clusterin and alpha-2-macroglobulin identified as significant interacting proteins.
  • The study highlights shared molecular pathways between cardiovascular and Alzheimer's diseases.

Conclusions:

  • Apolipoprotein E, haptoglobin, clusterin, and alpha-2-macroglobulin are potential key targets in the CVD/AD axis.
  • These proteins may serve as future biomarkers or therapeutic targets for AD and CVD.
  • Further research is necessary to fully elucidate the roles of these identified proteins.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
713
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
383
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.5K